Rebecca De Lorenzo

Dr. Rebecca De Lorenzo is an internist at the General Medicine Unit with a focus on metabolic health and aging at IRCCS Ospedale San Raffaele. She also collaborates with IRCCS Ospedale San Raffaele Turro.

She graduated in Medicine and Surgery in 2017 from Università Vita-Salute San Raffaele, where she specialized in Internal Medicine in 2023. In 2017, she spent a period of study and research in the United States at the Johns Hopkins Myositis Center and the Muscle Disease Unit of the National Institutes of Health (NIH), under the guidance of Prof. Andrew Mammen. Her training was recognized with a grant for studying the pathophysiological mechanisms behind scleroderma and with the Anna Kuliscioff award as the best young medical researcher in 2023.

Dr. De Lorenzo's professional activity combines clinical work with scientific research in the Laboratory of Innate Immunity and Tissue Remodeling, directed by Prof. Patrizia Rovere-Querini.

Initially focused on autoimmune diseases and inflammatory myositis, her research evolved during the pandemic towards managing COVID-19 patients, taking on the responsibility of the Long COVID clinic, where she followed about 3,000 patients. Currently, her clinical and research focus has shifted towards metabolic alterations in obesity, with particular attention to muscle mitochondrial function in sarcopenia associated with obesity and inflammatory mechanisms linking these conditions.

Currently, her clinical activity takes place at the Center of Excellence for Metabolic Health at Ospedale San Raffaele, where she deals with patients with overweight, obesity, and/or metabolic syndrome. Dr. De Lorenzo has published 77 articles in high-impact international journals, with an h-index of 27.